Oxycodone Hydrochloride Tablet
Product Images NDC 76420-763

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Oxycodone Hydrochloride (NDC 76420-763). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

15mg-label (15mg Label)

15mg-label (15mg Label)
This image displays multiple packaging labels for Oxycodone Hydrochloride Tablets USP 15 mg by Enovachem Pharmaceuticals. Labels include various NDCs corresponding to different package quantities such as 10, 20, 30, 60, 90, 100, and 500 tablets. Each label includes standard drug information, a QR code, CII drug classification, and storage instructions, with consistent design elements and distributor details by Alvogen, Inc.*
FDA Label Image

30mg-label (30mg Label)

30mg-label (30mg Label)
Multiple labels for Oxycodone Hydrochloride Tablets USP 30 mg, relabeled and packaged by Enovachem Pharmaceuticals at 379 Van Ness Ave, Torrance, CA. Labels show various quantities including 10, 20, 30, 60, 90, 100, and 500 tablets. Tablets are described as blue, round, biconvex, and debossed (ALG 265). Distributed by Alvogen, Inc. Each label contains a QR code, NDC 76420-768, and drug status CII.*
FDA Label Image

5mg-label (5mg Label)

5mg-label (5mg Label)
Labels for Oxycodone Hydrochloride Tablets USP 5 mg by Enovachem Pharmaceuticals showing various package sizes: 10, 20, 30, 60, 90, 100, and 500 count. The labels include NDC numbers, barcodes, controlled substance status (CII), distributor information (Alvogen, Inc.), and cautions about prescription and storage.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A pharmacokinetic concentration-time curve showing the plasma concentration of oxycodone 5 mg at doses of 1, 3, and 6 tablets over a 24-hour period. The graph depicts concentration (ng/mL) on the vertical axis versus time (hours) on the horizontal axis, illustrating dose-dependent increases and gradual decline in oxycodone levels.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of oxycodone hydrochloride showing its molecular framework with hydroxyl, methoxy, and other functional groups, including the hydrochloride (HCl) moiety, consistent with the active ingredient oxycodone hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.